肝动脉塞栓化疗治疗原发性肝癌

Hepaticarterial chemombilization treatment for hepatocellular carcinoma

目的 :研究肝动脉塞栓化疗治疗原发性肝癌的效果。方法 :对 380例肝癌患者实行肝动脉塞栓化疗。采用Seldinger方法经股动脉穿刺插管 ,药物选用ADM ,MMC ,5 -Fu ,DDP联合化疗。结果 :本组半年、1年、2年、3年生存率分别为 :78.3%、37.4 %、19.6%和 7.3% ,复查有明显肿块缩小( 30 %以上 )的患者达 83.3% ( 175 / 2 10 ) ,缩小 30 %以下或无变化者 2 3例 ,占 11%。结论 :肝动脉塞栓化疗对原发性肝癌有明显效果。

Objective: To study the effect of hepaticarterial chemombilization (HACE) treating for hepatocellular carcinoma (HCC). Methods: 380 cases with HCC treated by HACE. We used seldinger method to puncture through femoral artery with ADM, MMC, 5-Fu combined DDP. Results: The survival rate of half year, 1year, 2 year, 3 year is following: 78.3%, 37.4%, 19.6% and 7.3%. Patients with tumor shrinking obviously (above 30%) after reexamination were 83.3% (175/210), tumor shrinking under 30% and no changes were 11% (23/210). Conclusion: HACE has effect on HCC.